Multiple third-generation recombinants formed by CRF55_01B and CRF07_BC in newly diagnosed HIV-1 infected patients in Shenzhen city, China
In the evolution landscape of HIV, the coexistence of multiple subtypes has led to new, complex recombinants, posing public health challenges. CRF55_01B, first identified among MSM in Shenzhen, China, has spread rapidly across China. In this study, 47 plasma samples from newly diagnosed HIV-1 CRF55_01B patients in Shenzhen, of which the genotype was only identified by the routine HIV drug resistance test, were collected. Multiple gene regions were acquired using Sanger and next-generation sequencing methods, followed by the phylogenetic reconstruction, recombination breakpoint scanning, Bayesian molecular clock, and the prediction of coreceptors. From 47 samples, we found seven new unique recombinants formed by CRF55_01B and CRF07_BC, which shared similar breakpoints in certain gene regions and primarily utilized CCR5 receptors. All of the most recent common ancestors of subregions for these recombinants were estimated to be later than CRF55_01B and CRF07_BC, potentially suggesting they are the third-generation recombinants formed by CRF55_01B and CRF07_BC as parents. The continuous emergence of new recombinants highlights the increasing complexity of circulating strains in Shenzhen, and also suggests that subtype analysis using partial pol gene may lead to an overestimation of the major subtype strains and an underestimation of new complex HIV recombinants. Consequently, to effectively address and mitigate the complex HIV epidemic, there is an urgent need for expanded monitoring and the optimization of testing methodologies.
Authors
- Jin Zhao (ORCID: https://orcid.org/0000-0002-6035-1828)
- Hong Shang (ORCID: https://orcid.org/0000-0001-5333-8943)
- Yongxia Gan (ORCID: https://orcid.org/0000-0002-5400-7449)
- Chenli Zheng (ORCID: https://orcid.org/0000-0002-0967-8518)
- Lin H. Chen (ORCID: https://orcid.org/0000-0002-5684-8436)
- Jiao Yan (ORCID: https://orcid.org/0000-0001-7303-316X)
- Hui Zhang (ORCID: https://orcid.org/0000-0002-0756-9334)
- Nan Zhang (ORCID: https://orcid.org/0000-0002-8309-4262)
- Yan Zhang (ORCID: https://orcid.org/0000-0001-5784-4659)
- Hao Li (ORCID: https://orcid.org/0000-0003-0938-2669)
- Xiaoxu Han (ORCID: https://orcid.org/0000-0003-1427-8428)
- Minghui An
Institutions
- Liaoning University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Shenzhen Center for Disease Control and Prevention (CN)
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Virology Journal
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1186/s12985-024-02563-z
- Citations
- 4
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.17
Funders
- National Natural Science Foundation of China
- China Medical University
- Department of Science and Technology of Liaoning Province
- Sanming Project of Medicine in Shenzhen